- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Antibody Development Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Antibody Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody Development Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Development Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Development Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, R&D Systems, Leinco Technologies, Rockland Immunochemicals, Inc. (Rockland) and Bio-Rad, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibody Development Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibody Development
Polyclonal Antibody Development
Market segment by Application
Medical Industry
Biological Industry
Others
Market segment by players, this report covers
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Development Services, with revenue, gross margin and global market share of Antibody Development Services from 2018 to 2023.
Chapter 3, the Antibody Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Development Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Development Services.
Chapter 13, to describe Antibody Development Services research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Antibody Development Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Development Services by Type
1.3.1 Overview: Global Antibody Development Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antibody Development Services Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibody Development
1.3.4 Polyclonal Antibody Development
1.4 Global Antibody Development Services Market by Application
1.4.1 Overview: Global Antibody Development Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Medical Industry
1.4.3 Biological Industry
1.4.4 Others
1.5 Global Antibody Development Services Market Size & Forecast
1.6 Global Antibody Development Services Market Size and Forecast by Region
1.6.1 Global Antibody Development Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antibody Development Services Market Size by Region, (2018-2029)
1.6.3 North America Antibody Development Services Market Size and Prospect (2018-2029)
1.6.4 Europe Antibody Development Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antibody Development Services Market Size and Prospect (2018-2029)
1.6.6 South America Antibody Development Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antibody Development Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Antibody Development Services Product and Solutions
2.1.4 Thermo Fisher Scientific Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 R&D Systems
2.2.1 R&D Systems Details
2.2.2 R&D Systems Major Business
2.2.3 R&D Systems Antibody Development Services Product and Solutions
2.2.4 R&D Systems Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 R&D Systems Recent Developments and Future Plans
2.3 Leinco Technologies
2.3.1 Leinco Technologies Details
2.3.2 Leinco Technologies Major Business
2.3.3 Leinco Technologies Antibody Development Services Product and Solutions
2.3.4 Leinco Technologies Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Leinco Technologies Recent Developments and Future Plans
2.4 Rockland Immunochemicals, Inc. (Rockland)
2.4.1 Rockland Immunochemicals, Inc. (Rockland) Details
2.4.2 Rockland Immunochemicals, Inc. (Rockland) Major Business
2.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product and Solutions
2.4.4 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rockland Immunochemicals, Inc. (Rockland) Recent Developments and Future Plans
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Antibody Development Services Product and Solutions
2.5.4 Bio-Rad Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 BioGenes
2.6.1 BioGenes Details
2.6.2 BioGenes Major Business
2.6.3 BioGenes Antibody Development Services Product and Solutions
2.6.4 BioGenes Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioGenes Recent Developments and Future Plans
2.7 ProteoGenix
2.7.1 ProteoGenix Details
2.7.2 ProteoGenix Major Business
2.7.3 ProteoGenix Antibody Development Services Product and Solutions
2.7.4 ProteoGenix Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ProteoGenix Recent Developments and Future Plans
2.8 Labcorp
2.8.1 Labcorp Details
2.8.2 Labcorp Major Business
2.8.3 Labcorp Antibody Development Services Product and Solutions
2.8.4 Labcorp Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Labcorp Recent Developments and Future Plans
2.9 Inotiv, Inc.
2.9.1 Inotiv, Inc. Details
2.9.2 Inotiv, Inc. Major Business
2.9.3 Inotiv, Inc. Antibody Development Services Product and Solutions
2.9.4 Inotiv, Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Inotiv, Inc. Recent Developments and Future Plans
2.10 ProMab Biotechnologies
2.10.1 ProMab Biotechnologies Details
2.10.2 ProMab Biotechnologies Major Business
2.10.3 ProMab Biotechnologies Antibody Development Services Product and Solutions
2.10.4 ProMab Biotechnologies Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ProMab Biotechnologies Recent Developments and Future Plans
2.11 Kemp Proteins
2.11.1 Kemp Proteins Details
2.11.2 Kemp Proteins Major Business
2.11.3 Kemp Proteins Antibody Development Services Product and Solutions
2.11.4 Kemp Proteins Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Kemp Proteins Recent Developments and Future Plans
2.12 Synaptic Systems
2.12.1 Synaptic Systems Details
2.12.2 Synaptic Systems Major Business
2.12.3 Synaptic Systems Antibody Development Services Product and Solutions
2.12.4 Synaptic Systems Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Synaptic Systems Recent Developments and Future Plans
2.13 ARVYS Proteins, Inc.
2.13.1 ARVYS Proteins, Inc. Details
2.13.2 ARVYS Proteins, Inc. Major Business
2.13.3 ARVYS Proteins, Inc. Antibody Development Services Product and Solutions
2.13.4 ARVYS Proteins, Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ARVYS Proteins, Inc. Recent Developments and Future Plans
2.14 BBI Solutions
2.14.1 BBI Solutions Details
2.14.2 BBI Solutions Major Business
2.14.3 BBI Solutions Antibody Development Services Product and Solutions
2.14.4 BBI Solutions Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 BBI Solutions Recent Developments and Future Plans
2.15 Innovagen AB
2.15.1 Innovagen AB Details
2.15.2 Innovagen AB Major Business
2.15.3 Innovagen AB Antibody Development Services Product and Solutions
2.15.4 Innovagen AB Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Innovagen AB Recent Developments and Future Plans
2.16 BIOTEM
2.16.1 BIOTEM Details
2.16.2 BIOTEM Major Business
2.16.3 BIOTEM Antibody Development Services Product and Solutions
2.16.4 BIOTEM Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BIOTEM Recent Developments and Future Plans
2.17 Medimab
2.17.1 Medimab Details
2.17.2 Medimab Major Business
2.17.3 Medimab Antibody Development Services Product and Solutions
2.17.4 Medimab Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Medimab Recent Developments and Future Plans
2.18 OriGene
2.18.1 OriGene Details
2.18.2 OriGene Major Business
2.18.3 OriGene Antibody Development Services Product and Solutions
2.18.4 OriGene Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 OriGene Recent Developments and Future Plans
2.19 Abeomics Inc.
2.19.1 Abeomics Inc. Details
2.19.2 Abeomics Inc. Major Business
2.19.3 Abeomics Inc. Antibody Development Services Product and Solutions
2.19.4 Abeomics Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Abeomics Inc. Recent Developments and Future Plans
2.20 RayBiotech
2.20.1 RayBiotech Details
2.20.2 RayBiotech Major Business
2.20.3 RayBiotech Antibody Development Services Product and Solutions
2.20.4 RayBiotech Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 RayBiotech Recent Developments and Future Plans
2.21 Genscript Biotech Corporation
2.21.1 Genscript Biotech Corporation Details
2.21.2 Genscript Biotech Corporation Major Business
2.21.3 Genscript Biotech Corporation Antibody Development Services Product and Solutions
2.21.4 Genscript Biotech Corporation Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Genscript Biotech Corporation Recent Developments and Future Plans
2.22 Sino Biological
2.22.1 Sino Biological Details
2.22.2 Sino Biological Major Business
2.22.3 Sino Biological Antibody Development Services Product and Solutions
2.22.4 Sino Biological Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Sino Biological Recent Developments and Future Plans
2.23 Abzena Ltd
2.23.1 Abzena Ltd Details
2.23.2 Abzena Ltd Major Business
2.23.3 Abzena Ltd Antibody Development Services Product and Solutions
2.23.4 Abzena Ltd Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Abzena Ltd Recent Developments and Future Plans
2.24 Creative Biolabs
2.24.1 Creative Biolabs Details
2.24.2 Creative Biolabs Major Business
2.24.3 Creative Biolabs Antibody Development Services Product and Solutions
2.24.4 Creative Biolabs Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Creative Biolabs Recent Developments and Future Plans
2.25 Abcam
2.25.1 Abcam Details
2.25.2 Abcam Major Business
2.25.3 Abcam Antibody Development Services Product and Solutions
2.25.4 Abcam Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Abcam Recent Developments and Future Plans
2.26 Antibodies Incorporated
2.26.1 Antibodies Incorporated Details
2.26.2 Antibodies Incorporated Major Business
2.26.3 Antibodies Incorporated Antibody Development Services Product and Solutions
2.26.4 Antibodies Incorporated Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Antibodies Incorporated Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antibody Development Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antibody Development Services by Company Revenue
3.2.2 Top 3 Antibody Development Services Players Market Share in 2022
3.2.3 Top 6 Antibody Development Services Players Market Share in 2022
3.3 Antibody Development Services Market: Overall Company Footprint Analysis
3.3.1 Antibody Development Services Market: Region Footprint
3.3.2 Antibody Development Services Market: Company Product Type Footprint
3.3.3 Antibody Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Antibody Development Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antibody Development Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Antibody Development Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Antibody Development Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Antibody Development Services Consumption Value by Type (2018-2029)
6.2 North America Antibody Development Services Consumption Value by Application (2018-2029)
6.3 North America Antibody Development Services Market Size by Country
6.3.1 North America Antibody Development Services Consumption Value by Country (2018-2029)
6.3.2 United States Antibody Development Services Market Size and Forecast (2018-2029)
6.3.3 Canada Antibody Development Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Antibody Development Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Antibody Development Services Consumption Value by Type (2018-2029)
7.2 Europe Antibody Development Services Consumption Value by Application (2018-2029)
7.3 Europe Antibody Development Services Market Size by Country
7.3.1 Europe Antibody Development Services Consumption Value by Country (2018-2029)
7.3.2 Germany Antibody Development Services Market Size and Forecast (2018-2029)
7.3.3 France Antibody Development Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antibody Development Services Market Size and Forecast (2018-2029)
7.3.5 Russia Antibody Development Services Market Size and Forecast (2018-2029)
7.3.6 Italy Antibody Development Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Antibody Development Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antibody Development Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antibody Development Services Market Size by Region
8.3.1 Asia-Pacific Antibody Development Services Consumption Value by Region (2018-2029)
8.3.2 China Antibody Development Services Market Size and Forecast (2018-2029)
8.3.3 Japan Antibody Development Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Antibody Development Services Market Size and Forecast (2018-2029)
8.3.5 India Antibody Development Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antibody Development Services Market Size and Forecast (2018-2029)
8.3.7 Australia Antibody Development Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Antibody Development Services Consumption Value by Type (2018-2029)
9.2 South America Antibody Development Services Consumption Value by Application (2018-2029)
9.3 South America Antibody Development Services Market Size by Country
9.3.1 South America Antibody Development Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Antibody Development Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Antibody Development Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Antibody Development Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antibody Development Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antibody Development Services Market Size by Country
10.3.1 Middle East & Africa Antibody Development Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Antibody Development Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antibody Development Services Market Size and Forecast (2018-2029)
10.3.4 UAE Antibody Development Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Antibody Development Services Market Drivers
11.2 Antibody Development Services Market Restraints
11.3 Antibody Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Antibody Development Services Industry Chain
12.2 Antibody Development Services Upstream Analysis
12.3 Antibody Development Services Midstream Analysis
12.4 Antibody Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Antibody Development Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antibody Development Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antibody Development Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antibody Development Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Antibody Development Services Product and Solutions
Table 8. Thermo Fisher Scientific Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. R&D Systems Company Information, Head Office, and Major Competitors
Table 11. R&D Systems Major Business
Table 12. R&D Systems Antibody Development Services Product and Solutions
Table 13. R&D Systems Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. R&D Systems Recent Developments and Future Plans
Table 15. Leinco Technologies Company Information, Head Office, and Major Competitors
Table 16. Leinco Technologies Major Business
Table 17. Leinco Technologies Antibody Development Services Product and Solutions
Table 18. Leinco Technologies Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Leinco Technologies Recent Developments and Future Plans
Table 20. Rockland Immunochemicals, Inc. (Rockland) Company Information, Head Office, and Major Competitors
Table 21. Rockland Immunochemicals, Inc. (Rockland) Major Business
Table 22. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product and Solutions
Table 23. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rockland Immunochemicals, Inc. (Rockland) Recent Developments and Future Plans
Table 25. Bio-Rad Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Major Business
Table 27. Bio-Rad Antibody Development Services Product and Solutions
Table 28. Bio-Rad Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bio-Rad Recent Developments and Future Plans
Table 30. BioGenes Company Information, Head Office, and Major Competitors
Table 31. BioGenes Major Business
Table 32. BioGenes Antibody Development Services Product and Solutions
Table 33. BioGenes Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioGenes Recent Developments and Future Plans
Table 35. ProteoGenix Company Information, Head Office, and Major Competitors
Table 36. ProteoGenix Major Business
Table 37. ProteoGenix Antibody Development Services Product and Solutions
Table 38. ProteoGenix Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. ProteoGenix Recent Developments and Future Plans
Table 40. Labcorp Company Information, Head Office, and Major Competitors
Table 41. Labcorp Major Business
Table 42. Labcorp Antibody Development Services Product and Solutions
Table 43. Labcorp Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Labcorp Recent Developments and Future Plans
Table 45. Inotiv, Inc. Company Information, Head Office, and Major Competitors
Table 46. Inotiv, Inc. Major Business
Table 47. Inotiv, Inc. Antibody Development Services Product and Solutions
Table 48. Inotiv, Inc. Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Inotiv, Inc. Recent Developments and Future Plans
Table 50. ProMab Biotechnologies Company Information, Head Office, and Major Competitors
Table 51. ProMab Biotechnologies Major Business
Table 52. ProMab Biotechnologies Antibody Development Services Product and Solutions
Table 53. ProMab Biotechnologies Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ProMab Biotechnologies Recent Developments and Future Plans
Table 55. Kemp Proteins Company Information, Head Office, and Major Competitors
Table 56. Kemp Proteins Major Business
Table 57. Kemp Proteins Antibody Development Services Product and Solutions
Table 58. Kemp Proteins Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Kemp Proteins Recent Developments and Future Plans
Table 60. Synaptic Systems Company Information, Head Office, and Major Competitors
Table 61. Synaptic Systems Major Business
Table 62. Synaptic Systems Antibody Development Services Product and Solutions
Table 63. Synaptic Systems Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Synaptic Systems Recent Developments and Future Plans
Table 65. ARVYS Proteins, Inc. Company Information, Head Office, and Major Competitors
Table 66. ARVYS Proteins, Inc. Major Business
Table 67. ARVYS Proteins, Inc. Antibody Development Services Product and Solutions
Table 68. ARVYS Proteins, Inc. Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ARVYS Proteins, Inc. Recent Developments and Future Plans
Table 70. BBI Solutions Company Information, Head Office, and Major Competitors
Table 71. BBI Solutions Major Business
Table 72. BBI Solutions Antibody Development Services Product and Solutions
Table 73. BBI Solutions Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. BBI Solutions Recent Developments and Future Plans
Table 75. Innovagen AB Company Information, Head Office, and Major Competitors
Table 76. Innovagen AB Major Business
Table 77. Innovagen AB Antibody Development Services Product and Solutions
Table 78. Innovagen AB Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Innovagen AB Recent Developments and Future Plans
Table 80. BIOTEM Company Information, Head Office, and Major Competitors
Table 81. BIOTEM Major Business
Table 82. BIOTEM Antibody Development Services Product and Solutions
Table 83. BIOTEM Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BIOTEM Recent Developments and Future Plans
Table 85. Medimab Company Information, Head Office, and Major Competitors
Table 86. Medimab Major Business
Table 87. Medimab Antibody Development Services Product and Solutions
Table 88. Medimab Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Medimab Recent Developments and Future Plans
Table 90. OriGene Company Information, Head Office, and Major Competitors
Table 91. OriGene Major Business
Table 92. OriGene Antibody Development Services Product and Solutions
Table 93. OriGene Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. OriGene Recent Developments and Future Plans
Table 95. Abeomics Inc. Company Information, Head Office, and Major Competitors
Table 96. Abeomics Inc. Major Business
Table 97. Abeomics Inc. Antibody Development Services Product and Solutions
Table 98. Abeomics Inc. Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Abeomics Inc. Recent Developments and Future Plans
Table 100. RayBiotech Company Information, Head Office, and Major Competitors
Table 101. RayBiotech Major Business
Table 102. RayBiotech Antibody Development Services Product and Solutions
Table 103. RayBiotech Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. RayBiotech Recent Developments and Future Plans
Table 105. Genscript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 106. Genscript Biotech Corporation Major Business
Table 107. Genscript Biotech Corporation Antibody Development Services Product and Solutions
Table 108. Genscript Biotech Corporation Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Genscript Biotech Corporation Recent Developments and Future Plans
Table 110. Sino Biological Company Information, Head Office, and Major Competitors
Table 111. Sino Biological Major Business
Table 112. Sino Biological Antibody Development Services Product and Solutions
Table 113. Sino Biological Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Sino Biological Recent Developments and Future Plans
Table 115. Abzena Ltd Company Information, Head Office, and Major Competitors
Table 116. Abzena Ltd Major Business
Table 117. Abzena Ltd Antibody Development Services Product and Solutions
Table 118. Abzena Ltd Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Abzena Ltd Recent Developments and Future Plans
Table 120. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 121. Creative Biolabs Major Business
Table 122. Creative Biolabs Antibody Development Services Product and Solutions
Table 123. Creative Biolabs Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Creative Biolabs Recent Developments and Future Plans
Table 125. Abcam Company Information, Head Office, and Major Competitors
Table 126. Abcam Major Business
Table 127. Abcam Antibody Development Services Product and Solutions
Table 128. Abcam Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Abcam Recent Developments and Future Plans
Table 130. Antibodies Incorporated Company Information, Head Office, and Major Competitors
Table 131. Antibodies Incorporated Major Business
Table 132. Antibodies Incorporated Antibody Development Services Product and Solutions
Table 133. Antibodies Incorporated Antibody Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Antibodies Incorporated Recent Developments and Future Plans
Table 135. Global Antibody Development Services Revenue (USD Million) by Players (2018-2023)
Table 136. Global Antibody Development Services Revenue Share by Players (2018-2023)
Table 137. Breakdown of Antibody Development Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 138. Market Position of Players in Antibody Development Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 139. Head Office of Key Antibody Development Services Players
Table 140. Antibody Development Services Market: Company Product Type Footprint
Table 141. Antibody Development Services Market: Company Product Application Footprint
Table 142. Antibody Development Services New Market Entrants and Barriers to Market Entry
Table 143. Antibody Development Services Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global Antibody Development Services Consumption Value (USD Million) by Type (2018-2023)
Table 145. Global Antibody Development Services Consumption Value Share by Type (2018-2023)
Table 146. Global Antibody Development Services Consumption Value Forecast by Type (2024-2029)
Table 147. Global Antibody Development Services Consumption Value by Application (2018-2023)
Table 148. Global Antibody Development Services Consumption Value Forecast by Application (2024-2029)
Table 149. North America Antibody Development Services Consumption Value by Type (2018-2023) & (USD Million)
Table 150. North America Antibody Development Services Consumption Value by Type (2024-2029) & (USD Million)
Table 151. North America Antibody Development Services Consumption Value by Application (2018-2023) & (USD Million)
Table 152. North America Antibody Development Services Consumption Value by Application (2024-2029) & (USD Million)
Table 153. North America Antibody Development Services Consumption Value by Country (2018-2023) & (USD Million)
Table 154. North America Antibody Development Services Consumption Value by Country (2024-2029) & (USD Million)
Table 155. Europe Antibody Development Services Consumption Value by Type (2018-2023) & (USD Million)
Table 156. Europe Antibody Development Services Consumption Value by Type (2024-2029) & (USD Million)
Table 157. Europe Antibody Development Services Consumption Value by Application (2018-2023) & (USD Million)
Table 158. Europe Antibody Development Services Consumption Value by Application (2024-2029) & (USD Million)
Table 159. Europe Antibody Development Services Consumption Value by Country (2018-2023) & (USD Million)
Table 160. Europe Antibody Development Services Consumption Value by Country (2024-2029) & (USD Million)
Table 161. Asia-Pacific Antibody Development Services Consumption Value by Type (2018-2023) & (USD Million)
Table 162. Asia-Pacific Antibody Development Services Consumption Value by Type (2024-2029) & (USD Million)
Table 163. Asia-Pacific Antibody Development Services Consumption Value by Application (2018-2023) & (USD Million)
Table 164. Asia-Pacific Antibody Development Services Consumption Value by Application (2024-2029) & (USD Million)
Table 165. Asia-Pacific Antibody Development Services Consumption Value by Region (2018-2023) & (USD Million)
Table 166. Asia-Pacific Antibody Development Services Consumption Value by Region (2024-2029) & (USD Million)
Table 167. South America Antibody Development Services Consumption Value by Type (2018-2023) & (USD Million)
Table 168. South America Antibody Development Services Consumption Value by Type (2024-2029) & (USD Million)
Table 169. South America Antibody Development Services Consumption Value by Application (2018-2023) & (USD Million)
Table 170. South America Antibody Development Services Consumption Value by Application (2024-2029) & (USD Million)
Table 171. South America Antibody Development Services Consumption Value by Country (2018-2023) & (USD Million)
Table 172. South America Antibody Development Services Consumption Value by Country (2024-2029) & (USD Million)
Table 173. Middle East & Africa Antibody Development Services Consumption Value by Type (2018-2023) & (USD Million)
Table 174. Middle East & Africa Antibody Development Services Consumption Value by Type (2024-2029) & (USD Million)
Table 175. Middle East & Africa Antibody Development Services Consumption Value by Application (2018-2023) & (USD Million)
Table 176. Middle East & Africa Antibody Development Services Consumption Value by Application (2024-2029) & (USD Million)
Table 177. Middle East & Africa Antibody Development Services Consumption Value by Country (2018-2023) & (USD Million)
Table 178. Middle East & Africa Antibody Development Services Consumption Value by Country (2024-2029) & (USD Million)
Table 179. Antibody Development Services Raw Material
Table 180. Key Suppliers of Antibody Development Services Raw Materials
List of Figures
Figure 1. Antibody Development Services Picture
Figure 2. Global Antibody Development Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antibody Development Services Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibody Development
Figure 5. Polyclonal Antibody Development
Figure 6. Global Antibody Development Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Antibody Development Services Consumption Value Market Share by Application in 2022
Figure 8. Medical Industry Picture
Figure 9. Biological Industry Picture
Figure 10. Others Picture
Figure 11. Global Antibody Development Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Antibody Development Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Antibody Development Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Antibody Development Services Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Antibody Development Services Consumption Value Market Share by Region in 2022
Figure 16. North America Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Antibody Development Services Revenue Share by Players in 2022
Figure 22. Antibody Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Antibody Development Services Market Share in 2022
Figure 24. Global Top 6 Players Antibody Development Services Market Share in 2022
Figure 25. Global Antibody Development Services Consumption Value Share by Type (2018-2023)
Figure 26. Global Antibody Development Services Market Share Forecast by Type (2024-2029)
Figure 27. Global Antibody Development Services Consumption Value Share by Application (2018-2023)
Figure 28. Global Antibody Development Services Market Share Forecast by Application (2024-2029)
Figure 29. North America Antibody Development Services Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Antibody Development Services Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Antibody Development Services Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Antibody Development Services Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Antibody Development Services Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Antibody Development Services Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 39. France Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Antibody Development Services Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Antibody Development Services Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Antibody Development Services Consumption Value Market Share by Region (2018-2029)
Figure 46. China Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 49. India Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Antibody Development Services Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Antibody Development Services Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Antibody Development Services Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Antibody Development Services Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Antibody Development Services Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Antibody Development Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Antibody Development Services Consumption Value (2018-2029) & (USD Million)
Figure 63. Antibody Development Services Market Drivers
Figure 64. Antibody Development Services Market Restraints
Figure 65. Antibody Development Services Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Antibody Development Services in 2022
Figure 68. Manufacturing Process Analysis of Antibody Development Services
Figure 69. Antibody Development Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
